inoper recurr breast-conserv surgic treatment radiotherapi factor inoper local recurr clinic patholog review patient stage II carcinoma breast breast-conserv oper megavoltag radiotherapi median follow-up period month local recurr unsuit salvag surgic treatment cent patient inoper recurr primari inflammatori carcinoma breast inoper failur patient invas ductal carcinoma presenc unfavor prognost featur posit node histolog grade neg estrogen receptor vascular invas lymphocyt stromal reaction doxorubicin-bas chemotherapi prognosi inoper recurr poor surviv time excess year receptor posit grade recurr tumor treatment hormon therapi 